Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-6.94	40.11	43.10
Graham Fair Price	3.82	48.58	46.79
PEG	-70.99	1.36	-4.68
Price/Book	8.33	3.11	2.87
Price/Cash Flow	7.86	80.47	74.61
Prices/Earnings	-11.84	20.30	23.03
Price/Sales	8.60	9.84	9.06
Price/FCF	7.86	80.47	74.61
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-20.02	0.47	0.59
Operating Margin	24.60	0.21	0.17
ROA	18.68	0.01	< 0.005
ROE	0.03	0.04	22.89
ROIC	0.01	0.02	41.49
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	0.03	-16.61
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.03	0.19	495.95
EPS QOQ	-0.05	0.15	203.83
FCF QOQ	-0.10	-0.04	61.87
Revenue QOQ	0.06	-0.04	-32.21
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.98	13.22	-26.44
Days Sales Outstanding (DSO)	40.21	40.24	0.09
Inventory Turnover	5.01	6.81	35.95
Debt/Capitalization	0.64	0.58	-8.39
Quick Ratio	0.68	0.76	11.32
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	55.92	52.37	-6.35
Cash	4.44	5.79	30.48
Capex	-2.05	-2.27	-10.65
Free Cash Flow	2.15	2.02	-5.93
Revenue	17.69	16.53	-6.58
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.91	0.94	3.27
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	15.85	14.47	-8.73
Naive Interpretation	Member

06 - Financial Health · Bad

Rating